• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管鳞状细胞癌中的异质性基因组畸变:综述

Heterogeneous genomic aberrations in esophageal squamous cell carcinoma: a review.

作者信息

Li Renling, Li Peng, Xing Wenqun, Qiu Huiling

机构信息

Quality and Standards Academy, Shenzhen Technology University Shenzhen 518060, China.

Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou 450008, China.

出版信息

Am J Transl Res. 2020 May 15;12(5):1553-1568. eCollection 2020.

PMID:32509161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269976/
Abstract

Esophageal cancer (EC) causes hundreds of thousands of deaths a year worldwide, especially the major subtype esophageal squamous cell carcinoma (ESCC). With the advent of next-generation sequencing and the availability of commercial microarrays, abnormities in genetic levels have been revealed in various independent researches. High frequencies of structure variations (SVs), single nucleotide variations (SNVs) and copy-number alterations (CNAs) in ESCCs are uncovered, and ESCC shows high levels of inter- and intratumor heterogeneity, implying diverse evolutionary trajectories. This review tries to explain the pathogenesis of ESCC on the scope of most often mutated genes based on prior studies, hopes to offer some hints for diagnosis and therapy in clinic.

摘要

食管癌(EC)每年在全球导致数十万人死亡,尤其是主要亚型食管鳞状细胞癌(ESCC)。随着下一代测序技术的出现以及商业微阵列的可得性,在各种独立研究中揭示了基因水平的异常。在ESCC中发现了高频的结构变异(SVs)、单核苷酸变异(SNVs)和拷贝数改变(CNAs),并且ESCC显示出高水平的肿瘤间和肿瘤内异质性,这意味着存在多种进化轨迹。本综述试图基于先前的研究,在最常发生突变的基因范围内解释ESCC的发病机制,希望能为临床诊断和治疗提供一些线索。

相似文献

1
Heterogeneous genomic aberrations in esophageal squamous cell carcinoma: a review.食管鳞状细胞癌中的异质性基因组畸变:综述
Am J Transl Res. 2020 May 15;12(5):1553-1568. eCollection 2020.
2
Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.食管组织从鳞状上皮异型增生到癌的遗传改变。
Gastroenterology. 2017 Jul;153(1):166-177. doi: 10.1053/j.gastro.2017.03.033. Epub 2017 Mar 30.
3
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.全基因组测序揭示食管鳞状细胞癌结构变异的多种模式。
Am J Hum Genet. 2016 Feb 4;98(2):256-74. doi: 10.1016/j.ajhg.2015.12.013. Epub 2016 Jan 28.
4
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.晚期食管鳞状细胞癌和食管腺癌的综合基因组分析揭示异同
Oncologist. 2015 Oct;20(10):1132-9. doi: 10.1634/theoncologist.2015-0156. Epub 2015 Sep 2.
5
Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌中肿瘤异质性的生物学意义
Cancers (Basel). 2019 Aug 12;11(8):1156. doi: 10.3390/cancers11081156.
6
Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.伴有和不伴有转移的浅表性食管鳞状细胞癌的全基因组拷贝数分析。
Oncotarget. 2017 Jan 17;8(3):5069-5080. doi: 10.18632/oncotarget.13847.
7
Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.食管鳞状细胞癌(ESCC)的基因组分析——精准医学的基础
Pathol Res Pract. 2017 Jul;213(7):836-841. doi: 10.1016/j.prp.2017.02.021. Epub 2017 Feb 28.
8
Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma.多区域全外显子组测序揭示食管鳞状细胞癌肿瘤内基因组异质性的显著动态变化。
Oncogenesis. 2015 Nov 30;4(11):e175. doi: 10.1038/oncsis.2015.34.
9
Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization.通过 array comparative genomic hybridization 检测食管发育不良和鳞状细胞癌之间的一致性和差异性遗传异常。
Clin Cancer Res. 2013 Nov 1;19(21):5867-78. doi: 10.1158/1078-0432.CCR-12-3753. Epub 2013 Sep 5.
10
Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.食管鳞状细胞癌中DNA甲基化与突变的综合分析
Mol Carcinog. 2016 Dec;55(12):2077-2088. doi: 10.1002/mc.22452. Epub 2016 Jan 12.

引用本文的文献

1
Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.食管鳞状细胞癌全球流行病学特征、筛查、早期诊断及预后预测的最新研究进展。
World J Gastroenterol. 2024 May 28;30(20):2638-2656. doi: 10.3748/wjg.v30.i20.2638.
2
Single-cell multi-omics in the study of digestive system cancers.单细胞多组学在消化系统癌症研究中的应用
Comput Struct Biotechnol J. 2023 Dec 12;23:431-445. doi: 10.1016/j.csbj.2023.12.007. eCollection 2024 Dec.
3
Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.分析食管鳞癌免疫治疗反应相关特征。
Front Immunol. 2023 Feb 2;14:1117658. doi: 10.3389/fimmu.2023.1117658. eCollection 2023.
4
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.PTK7,一种催化失活的受体酪氨酸激酶,增加了食管鳞状细胞癌 KYSE-30 细胞异种移植瘤的致癌表型。
Int J Mol Sci. 2022 Feb 21;23(4):2391. doi: 10.3390/ijms23042391.
5
Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy.剖析接受手术联合紫杉醇加铂类化疗的食管鳞状细胞癌患者的单细胞转录组网络。
Oncogenesis. 2021 Oct 26;10(10):71. doi: 10.1038/s41389-021-00359-2.
6
Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis.程序性细胞死亡配体1在未经术前治疗的食管鳞状细胞癌患者中的预后作用:一项系统评价和荟萃分析
Front Oncol. 2021 Aug 18;11:693886. doi: 10.3389/fonc.2021.693886. eCollection 2021.
7
Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma.鉴定 PDHX 为食管鳞癌的代谢靶标。
Cancer Sci. 2021 Jul;112(7):2792-2802. doi: 10.1111/cas.14938. Epub 2021 May 24.

本文引用的文献

1
Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.鉴定 ANO1(anoctamin 1)为嗜酸性粒细胞性食管炎中食管上皮细胞增殖的关键驱动因素。
J Allergy Clin Immunol. 2020 Jan;145(1):239-254.e2. doi: 10.1016/j.jaci.2019.07.049. Epub 2019 Oct 21.
2
An NF90/long noncoding RNA-LET/miR-548k feedback amplification loop controls esophageal squamous cell carcinoma progression.一种NF90/长链非编码RNA-LET/miR-548k反馈放大环控制食管鳞状细胞癌进展。
J Cancer. 2019 Aug 28;10(21):5139-5152. doi: 10.7150/jca.30816. eCollection 2019.
3
Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.食管鳞癌从正常黏膜到原发肿瘤和转移灶的克隆进化。
Carcinogenesis. 2019 Dec 31;40(12):1445-1451. doi: 10.1093/carcin/bgz162.
4
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.多区域测序揭示了食管鳞癌中的新的可操作靶点和空间异质性。
Nat Commun. 2019 Apr 11;10(1):1670. doi: 10.1038/s41467-019-09255-1.
5
UTX Mutations in Human Cancer.UTX 基因突变与人类癌症。
Cancer Cell. 2019 Feb 11;35(2):168-176. doi: 10.1016/j.ccell.2019.01.001.
6
Age-related remodelling of oesophageal epithelia by mutated cancer drivers.由突变的癌症驱动因子引起的食管上皮的年龄相关性重塑。
Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2.
7
Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers.单细胞 RNA 测序揭示了两种食管癌的肿瘤内异质性和基因特征的多样性。
Cancer Lett. 2018 Dec 1;438:133-143. doi: 10.1016/j.canlet.2018.09.017. Epub 2018 Sep 15.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.染色体 11q13.3 扩增相关的淋巴结转移是由 miR-548k 通过调节肿瘤微环境驱动的。
Mol Cancer. 2018 Aug 21;17(1):125. doi: 10.1186/s12943-018-0871-4.
10
FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.头颈部癌中 FAT1 体细胞突变与肿瘤进展和生存相关。
Carcinogenesis. 2018 Dec 13;39(11):1320-1330. doi: 10.1093/carcin/bgy107.